These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8160476)

  • 1. Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis.
    Chait A
    West J Med; 1994 Feb; 160(2):183-4. PubMed ID: 8160476
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth-promoting effects of oxidized low density lipoprotein.
    Zettler ME; Pierce GN
    Can J Cardiol; 2001 Jan; 17(1):73-9. PubMed ID: 11173317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of low-density lipoprotein in the pathogenesis of atherosclerosis].
    Zák A; Rublicová J; Skorepa J
    Cas Lek Cesk; 1978 Oct; 117(42):1305-10. PubMed ID: 214233
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of intrinsic low density lipoprotein in the vascular wall. Significance for the pathogenesis of essential hypertension and arteriosclerosis].
    Sachinidis A; Ko Y; Vetter W; Vetter H
    Med Klin (Munich); 1994 Dec; 89(12):662-7. PubMed ID: 7870001
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory action of silibinin on low density lipoprotein oxidation.
    Locher R; Suter PM; Weyhenmeyer R; Vetter W
    Arzneimittelforschung; 1998 Mar; 48(3):236-9. PubMed ID: 9553679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction by oxidized LDL].
    Kume N
    Nihon Ronen Igakkai Zasshi; 2000 May; 37(5):360-2. PubMed ID: 10936924
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.
    Hamilton CA
    Pharmacol Ther; 1997; 74(1):55-72. PubMed ID: 9336016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low density lipoprotein--an extreme example of lipoprotein heterogeneity.
    Steinberg D
    Isr J Med Sci; 1996 Jun; 32(6):469-72. PubMed ID: 8682653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of increased low-density lipoprotein oxidation in patients with hypercholesterolemia.
    Stalenhoef AF
    Nutrition; 1994; 10(6):564-6. PubMed ID: 7703607
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of ixidized low density lipoprotein in atherosclerosis].
    Hansen PR
    Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oxidation hypothesis of atherosclerosis.
    Rajman I; Kendall M; Cramb R
    Lancet; 1994 Nov; 344(8933):1363-4. PubMed ID: 7968044
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
    Cox DA; Cohen ML
    Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein oxidation.
    Iuliano L; Micheletta F; Violi F
    Ital Heart J; 2001 Dec; 2(12):867-72. PubMed ID: 11838329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].
    Belova LA; Ogloblina OG; Belov AA; Kukharchuk VV
    Vopr Med Khim; 2000; 46(1):8-21. PubMed ID: 10802881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of atherogenic low density lipoproteins (LDL) in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Arai H; Nagano Y
    Ann N Y Acad Sci; 1990; 598():188-93. PubMed ID: 2248438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.